Page last updated: 2024-12-07

1,2-dilauroylphosphatidylethanolamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

1,2-dilauroylphosphatidylethanolamine (DLPE) is a synthetic phospholipid with two lauric acid chains attached to the glycerol backbone. It is commonly used in research as a model compound for studying the properties of phospholipids and their interactions with other molecules. DLPE is a saturated phospholipid, which means that it has no double bonds in its fatty acid chains. This makes it a relatively rigid molecule, which can influence its interactions with other molecules and its behavior in membranes. DLPE is synthesized by reacting glycerol with lauric acid in the presence of a catalyst. DLPE is studied because it is a simple model compound that can be used to investigate the fundamental properties of phospholipids. This knowledge can then be applied to the study of more complex phospholipids found in biological membranes. DLPE is also used in the development of new drug delivery systems. Due to its rigid structure, DLPE is a good candidate for forming liposomes, which are small, spherical vesicles that can encapsulate and deliver drugs to target cells. DLPE can also be used to create other types of nanomaterials for drug delivery and other applications.'

Cross-References

ID SourceID
PubMed CID122254
MeSH IDM0050656

Synonyms (8)

Synonym
1,2-dilauroylphosphatidylethanolamine
53695-34-4
dlpe-lauroyl
1,2-dilauroyl-sn-glycerophosphoethanolamine
dodecanoic acid, 1-((((2-aminoethoxy)hydroxyphosphinyl)oxy)methyl)-1,2-ethanediyl ester, acetate
DTXSID40968458
acetic acid--3-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(dodecanoyloxy)propyl dodecanoate (1/1)
acetic acid;[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] dodecanoate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (21.05)18.7374
1990's19 (50.00)18.2507
2000's9 (23.68)29.6817
2010's2 (5.26)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.79 (24.57)
Research Supply Index3.66 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]